海外の治験の状況「濾胞性リンパ腫」での検索結果
59件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Study Comparing MK-8808 to MabThera™ in Patients with Advanced Follicular Lymphoma.
- Previously untreated patients with CD20-positive follicular lymphoma, Grade 1, 2 or 3a according to the WHO 2008 classification system. MedDRA version: 14.1 Level: LLT Classification code 10059432 Term: Follicular mixed small and large cell lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belarus, Brazil, Canada, Chile, China, Croatia, Egypt, Georgia, India, Israel, Italy, Korea, Republic of, Malaysia, Mexico, New Zealand, Peru, Philippines, Russian Federation, Singapore, South Africa, Taiwan, Thailand, Ukraine
- 2013-01-11
Authorised
- A Study to Compare Efficacy and Safety between CT-P10 and Rituxan in Patients with Low Tumour Burden Follicular Lymphoma
- Low Tumour Burden Follicular Lymphoma. br>MedDRA version: 20.0 Level: PT Classification code 10065856 Term: Non-Hodgkin's lymphoma unspecified histology indolent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belarus, Brazil, Chile, Czech Republic, Georgia, India, Israel, Italy, Japan, Korea, Republic of, Latvia, Malaysia, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Spain, Taiwan, Thailand, Ukraine, United Kingdom, United States
- 2015-09-24
Recruiting
- A study comparing PF-05280586 to MabThera® (rituximab) in patients with follicular lymphoma who have not received previous treatment.
- CD20-positive, low tumor burden, Follicular Lymphoma
- Austria, Belarus, Belgium, Brazil, Canada, Croatia, Egypt, France, Germany, Greece, India, Italy, Japan, Lebanon, Mexico, Other, Peru, Philippines, Poland, Portugal, Republic of Korea, Romania, Russian Federation, South Africa, Spain, Switzerland, Thailand, Turkey, Ukraine, United Kingdom, United States of America
- 2015-05-26
Authorised
- A Study Comparing SAIT101 to MabThera® in Patients with Low Tumor Burden Follicular Lymphoma
- Low Tumor Burden Follicular Lymphoma (LTBFL) br>MedDRA version: 19.0 Level: HLGT Classification code 10025320 Term: Lymphomas non-Hodgkin's B-cell System Organ Class: 10005329 - Blood and lymphatic system disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, Chile, Croatia, Czech Republic, Egypt, France, Georgia, Germany, Hong Kong, Hungary, India, Italy, Korea, Republic of, Latvia, Mexico, Philippines, Romania, Russian Federation, Saudi Arabia, Serbia, South Africa, Spain, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2016-09-07
Not Recruiting
- A study of GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (a type of cancer)
- Advanced Stage Follicular Lymphoma
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, France, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine
- 2012-04-19
Not recruiting
- A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma
- Lymphoma, Follicular
- Argentina, Australia, Brazil, Canada, Czech Republic, Denmark, Ecuador, Finland, France, Israel, Italy, Korea, Republic of, Mexico, Norway, Peru, Poland, Russian Federation, Slovakia, Spain, Sweden, Switzerland, United Kingdom
- 2009-06-16
Not recruiting
- Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
- Lymphoma, Follicular
- Argentina, Czech Republic, France, Italy, Spain, Switzerland, United Kingdom, United States
- 2010-11-26
Not recruiting
- GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma
- Follicular Lymphoma
- Argentina, Australia, Austria, Brazil, Bulgaria, Colombia, France, Germany, Greece, Hungary, India, Ireland, Israel, Italy, Japan, Malaysia, Netherlands, Peru, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
- 2011-08-17
Recruiting
- A STUDY TO COMPARE EFFICACY AND SAFETY BETWEEN CT-P10 AND RITUXAN IN PATIENTS WITH LOW TUMOUR BURDEN FOLLICULAR LYMPHOMA
- -C829 Follicular lymphoma, unspecified br>Follicular lymphoma, unspecified;Follicular lymphoma, unspecified
- Australia, Chile, Czech Republic, Georgia, India, Israel, Italy, Korea South, Latvia, Malasya, Mexico, Poland, Portugal, Romania, Russian Federation, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kindgdom, United States
- 2016-04-05
Not Recruiting
- A study to Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
- Low Tumour Burden Follicular Lymphoma
- Australia, Brazil, Chile, Czech Republic, Georgia, India, Israel, Italy, Latvia, Malaysia, Mexico, Peru, Poland, Portugal, Republic of Korea, Romania, Russian Federation, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States of America
- 2016-01-07